Path Central

Irvine, United States Founded: 2009 • Age: 17 yrs Acquired By Xifin
A web-based anatomic pathology LIS is provided for pathologists.

About Path Central

Path Central is a Healthcare company based in Irvine (United States) founded in 2009, and was acquired by Xifin in August 2013. A web-based anatomic pathology LIS is provided for pathologists. Path Central has raised $14.91 million across 3 funding rounds from investors including Xifin, Okapi Venture Capital and Arboretum Ventures. The company was acqui-hired. Its focus areas include HealthTech, Healthcare IT, Provider and Hospital Information Systems. Its competitors include Waters Corporation, Ovation and Labvantage; 1 of its 3 listed competitors has raised funding.

Company details

Path Central was founded in 2009 in Irvine, United States, as a technology company focused on pathology software. A web-based Laboratory Information System is offered, integrating ordering, workflow management, specimen tracking, transcription, diagnosis, reporting, billing, and financial analysis for pathology practices. The company was acquired by XIFIN in August 2013.

Key Metrics
  • Total Equity Funding
    $14.91M (USD)

    in 3 rounds

  • Latest Funding Round
    $1.91M (USD), Series B

    Nov 2012

  • Investors
    Xifin

    & 3 more

  • Acquired by
    Xifin

    (Aug 2013)

Funding Insights of Path Central

Path Central has successfully raised a total of $14.91M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $1.91 million completed in November 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $14.91M
  • Total Rounds 3
  • Last Round Series B β€” $1.91M
  • First Round $10M

    (Nov 2010)

  • Investors Count 3

All 3 funding rounds of Path Central with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2012$1.91MSeries B––
–
Aug 2011$3MSeries B––
–
Nov 2010$10MSeries B–Okapi Venture Capital, Arboretum Ventures
–
Valuation history

4 investors in total: 4 institutional.

Investors in Path Central

Path Central has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Xifin, Okapi Venture Capital and Arboretum Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
US focused VC investment company
okapivc.comNewport Beach, United States
Healthcare venture capital investments are made by Arboretum Ventures.
arboretumvc.comAnn Arbor, United States
Global private equity and venture capital investments in B2B Tech & Services companies.
bairdcapital.com
Cloud-based billing & revenue cycle management solutions for diagnostic service providers
1997xifin.comSan Diego, United States
Premium access

Investor details for Path Central

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Path Central

4 dated milestones of Path Central across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Path Central is founded.
  2. Funding First funding round of $10.0M.
  3. Funding Latest funding round, Series B, of $1.9M.
  4. Exit Acquired by Xifin.

Competitors of Path Central

Path Central has 3 listed competitors in our database, 1 of them funded. They include Waters Corporation, Ovation and Labvantage.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
waters.com1958Milford, United States9,341
Provider of laboratory management system for researchers and clinicians
ovation.io2009Cambridge, United States$33.28M35
Cloud-based platform for laboratory data management and collaboration is provided.
labvantage.com1989Somerset, United States100
LIMS, Quality ELN and Business Intelligence solutions for laboratory
Premium access

Detailed competitors of Path Central

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Path Central (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Path Central

Premium access

Complete news archive for Path Central

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Path Central

Path Central was founded in 2009 and raised its 1st funding round 1 year after it was founded.

Path Central is headquartered in Irvine, United States. It is registered at Irvine, California, United States.

Path Central is a funded company, having raised a total of $14.91M across 3 funding rounds to date. The company's 1st funding round was a Series B of $10M, raised on Nov 2010.

Path Central was founded in 2009 in Irvine, United States, as a technology company focused on pathology software. A web-based Laboratory Information System is offered, integrating ordering, workflow management, specimen tracking, transcription, diagnosis, reporting, billing, and financial analysis for pathology practices. The company was acquired by XIFIN in August 2013.

Path Central's top competitors include Ovation, Waters Corporation and Labvantage.

Path Central has 4 investors. Key investors include Xifin, Okapi Venture Capital, Arboretum Ventures, and Baird Capital.

Yes. Path Central was acquired by Xifin in August 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available